376 related articles for article (PubMed ID: 27548267)
21. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
22. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
Bataller R; Rombouts K; Altamirano J; Marra F
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
[TBL] [Abstract][Full Text] [Related]
23. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review.
Ajmera VH; Terrault NA; Harrison SA
Hepatology; 2017 Jun; 65(6):2090-2099. PubMed ID: 28100008
[TBL] [Abstract][Full Text] [Related]
24. The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease.
Boyle M; Masson S; Anstee QM
J Hepatol; 2018 Feb; 68(2):251-267. PubMed ID: 29113910
[TBL] [Abstract][Full Text] [Related]
25. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease in the metabolic syndrome.
Palasciano G; Moschetta A; Palmieri VO; Grattagliano I; Iacobellis G; Portincasa P
Curr Pharm Des; 2007; 13(21):2193-8. PubMed ID: 17627552
[TBL] [Abstract][Full Text] [Related]
27. Histological assessment of non-alcoholic fatty liver disease.
Hübscher SG
Histopathology; 2006 Nov; 49(5):450-65. PubMed ID: 17064291
[TBL] [Abstract][Full Text] [Related]
28. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
[TBL] [Abstract][Full Text] [Related]
29. [Non-alcoholic steatohepatitis - from NAFLD to MAFLD].
Balmer ML; Dufour JF
Ther Umsch; 2011 Apr; 68(4):183-8. PubMed ID: 21452138
[TBL] [Abstract][Full Text] [Related]
30. Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality.
Younossi Z; Henry L
Gastroenterology; 2016 Jun; 150(8):1778-85. PubMed ID: 26980624
[TBL] [Abstract][Full Text] [Related]
31. Biphasic effect of alcohol intake on the development of fatty liver disease.
Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
[TBL] [Abstract][Full Text] [Related]
32. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
33. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
[TBL] [Abstract][Full Text] [Related]
34. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
35. Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease.
Åberg F; Puukka P; Salomaa V; Männistö S; Lundqvist A; Valsta L; Perola M; Jula A; Färkkilä M
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):995-997.e2. PubMed ID: 31255807
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
Craciun A; Lackner C; Cortez-Pinto H
Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
[TBL] [Abstract][Full Text] [Related]
37. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease.
Day CP
Liver Int; 2006 Nov; 26(9):1021-8. PubMed ID: 17032401
[TBL] [Abstract][Full Text] [Related]
38. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.
Malnick SDH; Alin P; Somin M; Neuman MG
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555867
[TBL] [Abstract][Full Text] [Related]
39. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.
Kim CH; Younossi ZM
Cleve Clin J Med; 2008 Oct; 75(10):721-8. PubMed ID: 18939388
[TBL] [Abstract][Full Text] [Related]
40. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
